Dulaglutide
Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk
Company n/r · Phase n/r · Completed · Enrollment 120000
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Injectable semaglutide | Obesity + T2D | n/r | n/r | n/r | n/r |
| Dulaglutide | Obesity + T2D | n/r | n/r | n/r | n/r |